Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 73
Filter
1.
Biochim Biophys Acta ; 1844(5): 1018-25, 2014 May.
Article in English | MEDLINE | ID: mdl-23806607

ABSTRACT

Differentiating malignant from nonmalignant biliary stenoses is challenging. This could be facilitated by the measurement of cancer biomarkers in bile. We aimed at (i) identifying new cancer biomarkers by comparative proteomic analysis of bile collected from patients with a malignant or benign biliary stenosis (exploratory phase) and (ii) verifying the accuracy of the newly identified potential biomarkers for discriminating malignant versus nonmalignant biliary stenoses in a larger group of patients (confirmation phase). Overall, 66 proteins were found overexpressed (ratio>1.5) in at least one cancer condition using proteomic analysis and 7 proteins were increased in all malignant/nonmalignant disease comparisons. Preliminary screening by immunoblot highlighted carcinoembryonic cell adhesion molecule 6 (CEAM6), a cell surface protein overexpressed in many human cancers, as an interesting candidate biomarker. ELISA subsequently confirmed CEAM6 as a potential bile biomarker for distinguishing malignant from benign biliary stenoses with a receiver operating characteristic (ROC) area under the curve (AUC) of 0.92 (specificity 83%, sensitivity 93%, positive predictive value 93%, and negative predictive value 83%). No significant difference in serum CEAM6 level was found between malignant and nonmalignant samples. Combining bile CEAM6 and serum CA19-9 in a panel further improved diagnostic accuracy for malignant stenoses (AUC 0.96, specificity 83%, sensitivity 97%, positive predictive value 93%, and negative predictive value 91%). CEAM6 measurement in bile could be clinically useful to discriminate between malignant and nonmalignant causes of biliary stenosis. This article is part of a Special Issue entitled: Biomarkers: A Proteomic Challenge.


Subject(s)
Antigens, CD/metabolism , Bile Duct Neoplasms/complications , Biomarkers, Tumor/metabolism , Cell Adhesion Molecules/metabolism , Cholestasis/diagnosis , Cholestasis/metabolism , Adenocarcinoma/complications , Adenocarcinoma/metabolism , Adult , Aged , Aged, 80 and over , Area Under Curve , Bile Duct Neoplasms/metabolism , Bile Ducts, Intrahepatic/metabolism , Bile Ducts, Intrahepatic/pathology , Cholangiocarcinoma/complications , Cholangiocarcinoma/metabolism , Cholestasis/etiology , Cohort Studies , Enzyme-Linked Immunosorbent Assay , Female , GPI-Linked Proteins/metabolism , Humans , Immunoblotting , Male , Middle Aged , Pancreatic Neoplasms/complications , Pancreatic Neoplasms/metabolism , Proteomics/methods , ROC Curve
2.
PLoS One ; 8(8): e72399, 2013.
Article in English | MEDLINE | ID: mdl-24015240

ABSTRACT

BACKGROUND: Interleukin (IL)-6 is recognised as an important cytokine involved in inflammatory diseases of the central nervous system (CNS). OBJECTIVE: To perform a large retrospective study designed to test cerebrospinal fluid (CSF) IL-6 levels in the context of neurological diseases, and evaluate its usefulness as a biomarker to help discriminate multiple sclerosis (MS) from other inflammatory neurological diseases (OIND). PATIENTS AND METHODS: We analyzed 374 CSF samples for IL-6 using a quantitative enzyme-linked immunosorbent assay. Groups tested were composed of demyelinating diseases of the CNS (DD, n = 117), including relapsing-remitting MS (RRMS, n = 65), primary progressive MS (PPMS, n = 11), clinically isolated syndrome (CIS, n = 11), optic neuritis (ON, n = 30); idiopathic transverse myelitis (ITM, n = 10); other inflammatory neurological diseases (OIND, n = 35); and non-inflammatory neurological diseases (NIND, n = 212). Differences between groups were analysed using Kruskal-Wallis test and Mann-Whitney U-test. RESULTS: CSF IL-6 levels exceeded the positivity cut-off of 10 pg/ml in 18 (51.4%) of the 35 OIND samples, but in only three (3.9%) of the 76 MS samples collected. CSF IL-6 was negative for all NIND samples tested (0/212). IL-6 cut-off of 10 pg/ml offers 96% sensitivity to exclude MS. CONCLUSION: CSF IL-6 may help to differentiate MS from its major differential diagnosis group, OIND.


Subject(s)
Interleukin-6/cerebrospinal fluid , Multiple Sclerosis, Chronic Progressive/cerebrospinal fluid , Multiple Sclerosis, Relapsing-Remitting/cerebrospinal fluid , Adult , Aged , Biomarkers/cerebrospinal fluid , Demyelinating Diseases/cerebrospinal fluid , Diagnosis, Differential , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Middle Aged , Multiple Sclerosis, Chronic Progressive/diagnosis , Multiple Sclerosis, Relapsing-Remitting/diagnosis , Myelitis, Transverse/cerebrospinal fluid , Optic Neuritis/cerebrospinal fluid , Young Adult
3.
J Proteomics ; 85: 12-27, 2013 Jun 24.
Article in English | MEDLINE | ID: mdl-23624238

ABSTRACT

Acute pancreatitis is an inflammatory disease of the pancreas, which varies greatly in course and severity. Severe forms are associated with serious local and/or systemic complications, and eventually death. The pathobiology of acute pancreatitis is complex. Animal models have been developed to investigate pathobiological processes and identify factors determining disease course. We performed a time-course proteomic analysis using a rat model of severe necrotizing acute pancreatitis induced by taurocholate perfusion in the pancreatic ducts. Results showed that levels of proteins associated to a given biological process changed in a coordinated fashion after disease onset. It was possible to follow the response of a particular pathobiological process to pancreatitis induction and to compare the course of protein pathways. Proteins involved in acinar cell secretion were found to follow a different kinetics than other cellular processes. After an initial decrease, secretory pathway-associated proteins raised again at 18 h post-induction. This phenomenon coincided with a burst in the expression of pancreatitis-associated protein (REG3A), an acute phase protein produced by the exocrine pancreas, and with the decrease of classical markers of pancreatic injury, suggesting that the expression of proteins associated to the secretory pathway may be a modulating factor of pancreas injury. BIOLOGICAL SIGNIFICANCE: Acute pancreatitis (AP) is a complex inflammatory disease, the pathobiology of which is not yet fully understood. Various animal models, relying on different mechanisms of disease induction, have been developed in order to investigate pathobiological processes of AP. In this study, we performed a time-course proteomic analysis to investigate changes of the pancreas proteome occurring in an experimental model of AP induced by perfusion of taurocholate, a bile acid, into the pancreatic duct. This experimental model is characterized by a severe disease with pancreatic necrosis and systemic inflammation. The objectives of this study were to determine the kinetics of functionally related proteins in the early steps of the experimental disease in order to identify protein pathways playing key roles in AP pathobiology and to correlate these data with parameters classically used to assess disease severity. The present work provides for the first time an overview of protein expression in the pancreas during the course of taurocholate-induced necrotizing AP. We believe that correlation of these results with data obtained using proteomic or biochemical approaches in various experimental models of AP will help in highlighting new features, generating hypotheses and constitute therefore a strong and reliable basis for further targeted investigations.


Subject(s)
Acinar Cells/metabolism , Biomarkers, Tumor/metabolism , Cholagogues and Choleretics/adverse effects , Pancreas, Exocrine/metabolism , Pancreatitis, Acute Necrotizing/metabolism , Taurocholic Acid/adverse effects , Acinar Cells/pathology , Animals , Antigens, Neoplasm , Biomarkers/metabolism , Cholagogues and Choleretics/pharmacology , Humans , Lectins, C-Type , Male , Pancreas, Exocrine/pathology , Pancreatitis, Acute Necrotizing/chemically induced , Pancreatitis, Acute Necrotizing/pathology , Pancreatitis-Associated Proteins , Proteomics , Rats , Rats, Sprague-Dawley , Taurocholic Acid/pharmacology , Time Factors
4.
J Proteomics ; 82: 193-229, 2013 Apr 26.
Article in English | MEDLINE | ID: mdl-23376485

ABSTRACT

Urine results from a coordinated activity of glomerular and tubular compartments of the kidney. As a footprint of these cellular functional processes, urinary exosomes, and 40-80 nm membrane vesicles released after fusion with the plasma membrane into the extracellular environment by renal epithelial cells, are a source for identification of proteins and investigation of their role in the kidney. The aim of the present study was the identification of podocyte exosome proteins based on urine immunoabsorption using podocyte-specific CR1-immunocoated beads followed by proteomic analysis using LC MS/MS techniques. This methodology allowed the identification of 1195 proteins. By using a bioinformatic approach, 27 brain-expressed proteins were identified, in which 14 out of them were newly demonstrated to be expressed in the kidney at a mRNA level, and, one of them, the COMT protein, was demonstrated to be expressed in podocytes at a protein level. These results, attesting the reliability of the methodology to identify podocyte proteins, need now to be completed by further experiments to analyze more precisely their biological function(s) in the podocytes.


Subject(s)
Exosomes/metabolism , Podocytes/metabolism , Proteome/metabolism , Proteomics/methods , Urine , Female , Humans , Mass Spectrometry/methods , Middle Aged
5.
PLoS One ; 7(9): e43830, 2012.
Article in English | MEDLINE | ID: mdl-23028472

ABSTRACT

BACKGROUND: Ability to accurately determine time of stroke onset remains challenging. We hypothesized that an early biomarker characterized by a rapid increase in blood after stroke onset may help defining better the time window during which an acute stroke patient may be candidate for intravenous thrombolysis or other intravascular procedures. METHODS: The blood level of 29 proteins was measured by immunoassays on a prospective cohort of stroke patients (N = 103) and controls (N = 132). Mann-Whitney U tests, ROC curves and diagnostic odds ratios were applied to evaluate their clinical performances. RESULTS: Among the 29 molecules tested, GST-π concentration was the most significantly elevated marker in the blood of stroke patients (p<0.001). More importantly, GST-π displayed the best area under the curve (AUC, 0.79) and the best diagnostic odds ratios (10.0) for discriminating early (N = 22, <3 h of stroke onset) vs. late stroke patients (N = 81, >3 h after onset). According to goal-oriented distinct cut-offs (sensitivity(Se)-oriented: 17.7 or specificity(Sp)-oriented: 65.2 ug/L), the GST-π test obtained 91%Se/50%Sp and 50%Se/91%Sp, respectively. Moreover, GST-π showed also the highest AUC (0.83) and performances for detecting patients treated with tPA (N = 12) compared to ineligible patients (N = 103). CONCLUSIONS: This study demonstrates that GST-π can accurately predict the time of stroke onset in over 50% of early stroke patients. The GST-π test could therefore complement current guidelines for tPA administration and potentially increase the number of patients accessing thrombolysis.


Subject(s)
Glutathione S-Transferase pi/blood , Stroke/blood , Stroke/diagnosis , Adult , Aged , Aged, 80 and over , Biomarkers/blood , Case-Control Studies , Female , Humans , Male , Middle Aged , Prognosis , Stroke/drug therapy , Time Factors , Tissue Plasminogen Activator/therapeutic use
6.
J Am Soc Mass Spectrom ; 23(10): 1750-6, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22869297

ABSTRACT

A mass spectrometry-based assay combining the specificity of selected reaction monitoring and the protein ion activation capabilities of electron transfer dissociation was developed and employed for the rapid identification of hemoglobin variants from whole blood without previous proteolytic cleavage. The analysis was performed in a robust ion trap mass spectrometer operating at nominal mass accuracy and resolution. Subtle differences in globin sequences, resulting with mass shifts of about one Da, can be unambiguously identified. These results suggest that mass spectrometry analysis of entire proteins using electron transfer dissociation can be employed on clinical samples in a workflow compatible with diagnostic applications.


Subject(s)
Hemoglobins/analysis , Mass Spectrometry/methods , Protein Subunits/analysis , Proteomics/methods , Chromatography, High Pressure Liquid , Hemoglobins/chemistry , Humans , Protein Subunits/chemistry
7.
Clin Chim Acta ; 413(13-14): 1145-50, 2012 Jul 11.
Article in English | MEDLINE | ID: mdl-22483794

ABSTRACT

Cerebrospinal fluid (CSF) rhinorrhea is a serious condition that may result in severe complications. Various laboratory tests, relying on the detection of CSF-specific proteins in nasal secretions, have been developed but diagnosis remains challenging. The aim of this study was to evaluate two new methods targeting either ß2-transferrin or beta-trace-protein. Rhinorrhea samples from patients suspected of CSF leakage (n=36) were analyzed using two-dimensional gel electrophoresis (2-DE) for CSF rhinorrhea diagnosis. Twelve patients with rhinorrhea strongly suggestive of a CSF leak also underwent a fluorescein test. The same cohort was retrospectively analyzed with a beta-trace protein immunoblot developed in-house (n=36) and a new commercial ß2-transferrin immunofixation assay (Sebia, Evry, France) (n=33). 2-DE was positive in 9 patients suffering from rhinorrhea following skull base fracture (n=3), post-surgery (n=4), or spontaneously (n=2). The 27 remaining cases were negative. These results were confirmed by the beta-trace protein immunoblot and ß2-transferrin immunofixation tests, except for one sample found negative with 2-DE but positive with the two other assays. Results from the three analytical methods were concordant with fluorescein tests. Beta-trace protein immunoblot and ß2-transferrin immunofixation assays are fast and reliable methods that allow detecting CSF leakage in nasal fluid with high sensitivity and specificity.


Subject(s)
Cerebrospinal Fluid Rhinorrhea/diagnosis , Immunoblotting/methods , Immunoelectrophoresis/methods , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Intramolecular Oxidoreductases/analysis , Lipocalins/analysis , Male , Middle Aged , Transferrin/analysis , Young Adult
8.
J Proteomics ; 75(15): 4656-67, 2012 Aug 03.
Article in English | MEDLINE | ID: mdl-22410244

ABSTRACT

Despite decades of intensive investigations, the precise sequence of molecular events and the specific proteins mediating the degenerative process underlying Parkinson's disease (PD) remain unraveled. Proteomic strategies may provide unbiased tools to identify novel candidates and explore original mechanisms involved in PD. Substantia nigra pars compacta (SN) tissue, whose degeneration is the hallmark of PD, was dissected from neuropathologically confirmed PD patients (n=3) and control subjects (n=3), before being submitted to a comparative 2-DE analysis. The present study revealed a subset of neuronal and/or glial proteins that appears to be deregulated in PD and likely to contribute to neurodegeneration. Observed alterations not only consolidate well accepted concepts surrounding PD pathogenesis such as oxidative stress and mitochondrial dysfunction but also point out to novel pathways. Among the latter, cytosolic non specific dipeptidase 2 (CNDP2), a relatively unknown protein not yet reported to be associated with PD pathogenesis, was shown to be increased in the SN of PD patients, as confirmed by Western blot. Immunohistochemical analyses demonstrated the presence of CNDP2 within the cytoplasm of SN dopaminergic neurons. Altogether, our findings support a key role of CNDP2 in PD neurodegeneration, by mechanisms that could involve oxidative stress, protein aggregation or inflammation. This article is part of a Special Issue entitled: Translational Proteomics.


Subject(s)
Dipeptidases/biosynthesis , Gene Expression Regulation, Enzymologic , Nerve Tissue Proteins/metabolism , Oxidative Stress , Parkinson Disease/metabolism , Substantia Nigra/metabolism , Aged , Aged, 80 and over , Dopaminergic Neurons/metabolism , Dopaminergic Neurons/pathology , Female , Humans , Immunohistochemistry/methods , Inflammation/metabolism , Inflammation/pathology , Male , Neuroglia/metabolism , Neuroglia/pathology , Parkinson Disease/pathology , Proteome , Substantia Nigra/pathology
9.
Proteomics ; 11(20): 3972-82, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21770033

ABSTRACT

During recent years, increased efforts have focused on elucidating the pluripotency and self-renewal of stem cells. Differentiation towards the different lineages has attracted significant attention given the potential use of stem cells in regenerative medicine. Embryonic stem cell differentiation is a complex process coordinated by strictly regulated extracellular signals that act in an autocrine and/or paracrine manner. Through secreted molecules, stem cells affect local niche biology and influence the cross-talking with the surrounding tissues. Emerging evidence supports the hypothesis that fundamental cell functions, including proliferation and differentiation, are strictly regulated by the complex set of molecules secreted from cells. The understanding of this molecular language could largely increase our knowledge on pathways regulating stem cell differentiation. Here, we have used a proteomics platform to investigate the profile of proteins secreted during differentiation of murine embryonic stem cells. We have followed the dynamics of protein secretion by comparing the secretomes at different time points of murine embryonic stem cell cardiac and neural differentiation. In addition to previously reported molecules, we have identified many secreted proteins not described so far as released from embryonic stem cells nor shown to be differentially released during the process of cardiomyogenesis and neurogenesis.


Subject(s)
Cell Differentiation , Embryonic Stem Cells , Myocytes, Cardiac/cytology , Neurons/cytology , Proteomics , Animals , Cell Lineage , Cell Survival , Embryonic Stem Cells/cytology , Embryonic Stem Cells/metabolism , Gas Chromatography-Mass Spectrometry , Mice , Polymerase Chain Reaction , Time Factors
10.
J Proteome Res ; 10(5): 2664-70, 2011 May 06.
Article in English | MEDLINE | ID: mdl-21425880

ABSTRACT

Pancreatic cystic neoplasms represent 10-15% of primary cystic masses of the pancreas. While pancreatic cysts are detected with an increasing frequency due to the use of advanced imaging modalities in clinical practice, the diagnosis of pancreatic cystic neoplasms remains unsatisfactory because available diagnostic techniques proved not sensitive enough so far. This study was designed to characterize the proteomic pattern of pancreatic cyst fluids obtained from various cystic lesions. Cyst fluids were collected by direct puncture during open surgery to avoid any possible contamination from other tissues. CEA, CA-19-9, and amylase concentrations were measured using specific immunoassays. After immunodepletion and fractionation by SDS-PAGE, proteins were digested and analyzed by LC-MS/MS. Specific histological lesions were found to be associated with distinct protein patterns. Interestingly, some of these proteins have been proposed as biomarkers of pancreatic cancer. Immunoblots allowed for verifying the differential expression in specific cyst fluids of two selected proteins, olfactomedin-4 and mucin-18. Finally, immunohistochemistry was performed to correlate these data with the expression pattern of olfactomedin-4 and mucin-18 in pancreatic cyst tissues. Results from this study indicate that proteomic analysis of cyst fluid could provide reliable candidates for developing new biomarkers for the preoperative management of malignant and premalignant pancreatic cysts.


Subject(s)
Biomarkers, Tumor/analysis , Cyst Fluid/chemistry , Pancreatic Cyst/diagnosis , Pancreatic Neoplasms/diagnosis , Proteomics/methods , Amylases/analysis , CA-19-9 Antigen/analysis , Carcinoembryonic Antigen/analysis , Chromatography, Liquid , Electrophoresis, Polyacrylamide Gel , Granulocyte Colony-Stimulating Factor/metabolism , Humans , Immunoassay , Immunoblotting , Immunohistochemistry , Mucins/metabolism , Pancreatic Cyst/metabolism , Pancreatic Neoplasms/metabolism , Tandem Mass Spectrometry
11.
J Proteome Res ; 10(4): 2047-63, 2011 Apr 01.
Article in English | MEDLINE | ID: mdl-21314112

ABSTRACT

Bile was shown to collect proteins known as potential cancer biomarkers. Thorough proteomic analysis of bile is of particular interest to search for new, more sensitive and more specific, biomarkers of cancers affecting the biliary tract and surrounding organs, such as the pancreas and the liver. Therefore, extending the knowledge of the bile proteome is highly relevant, but this has proved technically difficult. In this study, we describe a strategy that circumvents problems related to the biochemical complexity of this sample and the presence of high concentrations of interfering substances. Bile collected from a patient suffering from a biliary stenosis caused by a pancreatic adenocarcinoma was fractionated by a differential centrifugation scheme, involving a stepwise increase in centrifugation speeds. Pellets and the final supernatant were further fractionated by polyacrylamide gel electrophoresis and proteins were in-gel digested prior to LC-MS/MS analysis. This approach allowed the identification of 445 unique proteins with at least two peptides (812 proteins if single-hit proteins were included), which represents a 3-fold increase in the knowledge of bile proteome. The subsequent literature comparison revealed that numerous biliary proteins identified in this sample were related to pancreas cancer. Immunoblot analysis of some known tumor markers revealed that they were preferentially associated with the soluble fraction rather than with pellets containing cellular components.


Subject(s)
Bile/chemistry , Proteins/analysis , Proteome/analysis , Biomarkers, Tumor/analysis , Chromatography, Liquid/methods , Databases, Protein , Digestive System Neoplasms/chemistry , Digestive System Neoplasms/metabolism , Electrophoresis, Gel, Two-Dimensional/methods , Humans , Molecular Sequence Data , Proteomics/methods , Tandem Mass Spectrometry/methods
12.
Methods Mol Biol ; 681: 449-58, 2011.
Article in English | MEDLINE | ID: mdl-20978982

ABSTRACT

Shotgun proteomics is a rapid and near universal strategy to identify proteins in complex protein mixtures. After protein digestion, the resulting peptide mixture is submitted to two orthogonal techniques: peptides are first separated according to their isoelectric point (pI) by isoelectric focusing (IEF) on immobilized pH gradient (IPG); after peptide extraction, they are then separated in the second dimension according to their hydrophobic properties by reverse phase liquid chromatography (RPLC). Finally, they are detected by tandem mass spectrometry (MS/MS) and proteins are matched by means of bioinformatics software.


Subject(s)
Chromatography, Liquid/methods , Isoelectric Focusing/methods , Proteomics/methods , Tandem Mass Spectrometry/methods , Analytic Sample Preparation Methods , Chromatography, Reverse-Phase , Databases, Protein , Hydrogen-Ion Concentration , Models, Molecular , Peptide Fragments/analysis , Peptide Fragments/isolation & purification , Peptide Fragments/metabolism , Protein Conformation , Proteins/analysis , Proteins/chemistry , Proteins/isolation & purification , Proteins/metabolism
13.
Methods Mol Biol ; 681: 459-72, 2011.
Article in English | MEDLINE | ID: mdl-20978983

ABSTRACT

Shotgun proteomics originated as a strategy to identify proteins in complex protein mixtures, but it is also possible to obtain information on relative quantitation with some adjustments to the procedure. After protein digestion, the resulting peptide mixture is labelled with isobaric tags. Then, labelled peptides are submitted to two orthogonal techniques: first, peptides are separated according to their isoelectric point (pI) by Off-Gel electrophoresis (OGE), a relatively new isoelectric focusing (IEF) technique; after peptide purification, they are then separated in a second dimension according to their hydrophobic properties by reversed-phase liquid chromatography (RPLC). Finally, following detection by mass spectrometry (MS) and sequencing by tandem mass spectrometry (MS/MS), proteins are matched by means of bioinformatics software, and protein ratios are calculated by comparing isobaric tagged reporter fragments to highlight the different expression of one protein in one sample relative to other samples.


Subject(s)
Chromatography, Liquid/methods , Electrophoresis/methods , Proteomics/methods , Tandem Mass Spectrometry/methods , Analytic Sample Preparation Methods , Animals , Cattle , Chromatography, Reverse-Phase , Databases, Protein , Hydrogen-Ion Concentration , Peptide Fragments/analysis , Peptide Fragments/chemistry , Peptide Fragments/isolation & purification , Statistics as Topic
14.
Chimia (Aarau) ; 64(3): 132-5, 2010.
Article in English | MEDLINE | ID: mdl-21140904

ABSTRACT

Quantification is a major task in proteomics. Among the different analytical strategies to enable peptide and protein quantification, tagging with isotopic labels has emerged as a practical, versatile, and efficient alternative. In particular, isobaric labels, such as TMT or iTRAQ, are now widely employed to make relative comparison of the protein amounts in separate biological samples with tandem mass spectrometry (MS/MS). We used herein a shotgun proteomic approach based on labelling with tandem mass tags (TMTs) for the relative quantification of proteins, and the absolute quantification of their tryptic peptides in human cerebrospinal fluid (CSF). First, the comparison of ante- and post-mortem CSF samples was carried out for the discovery of protein marker candidates of brain-damage disorders. Second, tryptic peptides representative of these candidates were measured in CSF using reporter-ion calibration curves. These works highlighted the advantages and limitations of such strategies for quantification purposes in proteomics.


Subject(s)
Brain Diseases/cerebrospinal fluid , Peptides/cerebrospinal fluid , Proteomics/methods , Tandem Mass Spectrometry/methods , Trypsin/chemistry , Amino Acid Sequence , Biomarkers/cerebrospinal fluid , Cerebrospinal Fluid/chemistry , Humans , Molecular Sequence Data , Spectrometry, Mass, Electrospray Ionization/methods , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Tandem Mass Spectrometry/instrumentation
15.
Anal Bioanal Chem ; 398(7-8): 3033-42, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20927508

ABSTRACT

A liquid chromatography separation with electrospray ionisation and tandem mass spectrometry detection method was developed for the simultaneous quantification of ten commonly handled cytotoxic drugs in a hospital pharmacy. These cytotoxic drugs are cytarabine, gemcitabine, methotrexate, etoposide phosphate, cyclophosphamide, ifosfamide, irinotecan, doxorubicin, epirubicin and vincristine. The chromatographic separation was carried out by RPLC in less than 21 min, applying a gradient elution of water and acetonitrile in the presence of 0.1% formic acid. MS/MS was performed on a triple quadrupole in selected reaction monitoring mode. The analytical method was validated to determine the limit of quantification (LOQ) and quantitative performance: lowest LOQs were between 0.25 and 2 ng mL(-1) for the ten investigated cytotoxic drugs; trueness values (i.e. recovery) were between 85% and 110%, and relative standard deviations for both repeatability and intermediate precision were always inferior to 15%. The multi-compound method was successfully applied for the quality control of pharmaceutical formulations and for analyses of spiked samples on potentially contaminated surfaces.


Subject(s)
Antineoplastic Agents/analysis , Chromatography, High Pressure Liquid/methods , Spectrometry, Mass, Electrospray Ionization/methods , Tandem Mass Spectrometry/methods , Humans , Quality Control
16.
J Proteome Res ; 9(11): 5929-42, 2010 Nov 05.
Article in English | MEDLINE | ID: mdl-20815342

ABSTRACT

Acute pancreatitis is an inflammatory disease of the pancreas, which can result in serious morbidity or death. Acute pancreatitis severity can be reduced in experimental models by preconditioning animals with a short hyperthermia prior to disease induction. Heat shock proteins 27 and 70 are key effectors of this protective effect. In this study, we performed a comparative proteomic analysis using a combination of liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis and isobaric tagging to investigate changes in pancreatic proteins expression that were associated with thermal stress, both in healthy rats and in a model of caerulein-induced pancreatitis. In agreement with previous studies, we observed modulation of heat shock and inflammatory proteins expression in response to heat stress or pancreatitis induction. We also identified numerous other proteins, whose pancreatic level changed following pancreatitis induction, when acute pancreatitis severity was reduced by prior thermal stress, or in healthy rats in response to hyperthermia. Interestingly, we showed that the expression of various proteins associated with the secretory pathway was modified in the different experimental models, suggesting that modulation of this process is involved in the protective effect against pancreatic tissue damage.


Subject(s)
Heat-Shock Response , Pancreatitis/metabolism , Proteomics/methods , Acute Disease , Animals , Ceruletide , Fever/blood , Fever/metabolism , Pancreatitis/chemically induced , Protective Agents , Rats
17.
J Proteome Res ; 9(9): 4535-44, 2010 Sep 03.
Article in English | MEDLINE | ID: mdl-20604530

ABSTRACT

We used a peptidomic approach for the analysis of the low molecular weight proteome in rat pancreatic tissue extracts. The goal was to develop a method that allows identifying endogenous peptides produced in the pancreas in the course of acute pancreatitis. The workflow combines peptides enrichment by centrifugal ultrafiltration, fractionation by isoelectric focusing, and LC-MS/MS analysis without prior enzymatic digestion. The method was assessed on pancreatic extracts from 3 rats with caerulein-induced pancreatitis and 3 healthy controls. A qualitative analysis of the peptide patterns obtained from the different samples was performed to determine the main biological processes associated to the identified peptides. Comparison of peptidomic and immunoblot data for alpha-tubulin, beta-tubulin and coatomer gamma showed that the correlation between the number of identified peptides and the protein abundance was variable. Nevertheless, peptidomic analysis highlighted inflammatory and stress proteins, which peptide pattern was related to acute pancreatitis pathobiology. For these proteins, the higher number of peptides in pancreatitis samples reflected an increase in protein abundance. Moreover, for murinoglobulin-1 or carboxypeptidase B, peptide pattern could be related to protein function. These data suggest that peptidomic analysis is a complementary approach to proteomics for investigating pathobiological processes involved in acute pancreatitis.


Subject(s)
Pancreatitis/metabolism , Peptides/chemistry , Proteome/chemistry , Proteomics/methods , Acute Disease , Amino Acid Sequence , Animals , Ceruletide , Chromatography, Liquid , Disease Models, Animal , Heat-Shock Proteins/chemistry , Heat-Shock Proteins/metabolism , Immunoblotting , Inflammation , Male , Molecular Sequence Data , Molecular Weight , Pancreatitis/chemically induced , Peptides/metabolism , Proteins/chemistry , Proteins/metabolism , Proteome/metabolism , Rats , Rats, Sprague-Dawley , Tandem Mass Spectrometry
18.
Trends Biotechnol ; 28(5): 225-9, 2010 May.
Article in English | MEDLINE | ID: mdl-20359762

ABSTRACT

Proteomics has stimulated the development of very powerful methods for protein analysis. Implementation of some of these methods in clinical chemistry laboratories could offer clinicians better tools for diagnosis, prognosis and therapeutic follow-up of human diseases. However, laboratory medicine activities are bound by a number of constraints and rules for ensuring quality of results for clinical practice. There is therefore a gap to be filled between the research and routine medical laboratories. In this opinion article, we present the proteomic methods that will most likely be implemented in clinical chemistry laboratories in the short term, and we discuss the major issues yet to be addressed before considering such a transfer.


Subject(s)
Chemistry, Clinical/methods , Proteomics/methods , Animals , Humans , Mass Spectrometry , Quality Control
19.
Anal Chem ; 82(3): 848-58, 2010 Feb 01.
Article in English | MEDLINE | ID: mdl-20058875

ABSTRACT

In the past few years, mass spectrometry (MS) has emerged as an efficient tool for the multiplexed peptide and protein concentration determination by isotope dilution. Despite the growing use of isobaric tagging to perform relative quantitation for the discovery of potential biomarkers in biological fluids, no real application has so far been presented for their absolute quantitation. Isobaric tandem mass tags (TMTs) were used herein for the selection and quantitation of tryptic peptides derived from brain damage related proteins in cerebrospinal fluid (CSF). Proteotypic tryptic peptide analogues were synthesized, prepared in four reference amounts, differentially labeled with four isobaric TMTs with reporter-ions at m/z = 128.1, 129.1, 130.1, and 131.1, and mixed with CSF sample previously labeled with TMT 126.1. Off-gel electrophoresis (OGE) was used as first-dimension separation of the pooled sample. The resulting fractions were analyzed with reversed-phase liquid chromatography (RP-LC) tandem mass spectrometry (MS/MS), using tandem time-of-flight (TOF/TOF) and hybrid linear ion trap-orbitrap (LTQ-OT) instruments. Under collision-induced dissociation (CID) or higher-energy C-trap dissociation (HCD), the release of the reporter fragments from the TMT-labeled peptide standards provided an internal calibration curve to assess the concentration of these peptides in the CSF. This tool also allowed identifying selectively these peptides in CSF as only the targeted peptides showed specific fragmentation pattern in the TMT reporter-ion zone of the tandem mass spectra. Assays for the concentration measurements of peptides from PARK7, GSTP1, NDKA, and S100B proteins in CSF were further characterized using this novel, efficient, and straightforward approach.


Subject(s)
Chromatography, High Pressure Liquid/methods , Peptides/cerebrospinal fluid , Spectrometry, Mass, Electrospray Ionization/methods , Trypsin/metabolism , Amino Acid Sequence , Calibration , Chromatography, High Pressure Liquid/standards , Chromatography, Reverse-Phase , Glutathione S-Transferase pi/chemistry , Glutathione S-Transferase pi/metabolism , Humans , Intracellular Signaling Peptides and Proteins/chemistry , Intracellular Signaling Peptides and Proteins/metabolism , Molecular Sequence Data , Nerve Growth Factors/chemistry , Nerve Growth Factors/metabolism , Oncogene Proteins/chemistry , Oncogene Proteins/metabolism , Protein Deglycase DJ-1 , S100 Calcium Binding Protein beta Subunit , S100 Proteins/chemistry , S100 Proteins/metabolism , Spectrometry, Mass, Electrospray Ionization/standards
20.
J Microbiol Methods ; 80(1): 56-62, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19913576

ABSTRACT

In bottom-up proteomics, rapid and efficient protein digestion is crucial for data reliability. However, sample preparation remains one of the rate-limiting steps in proteomics workflows. In this study, we compared the conventional trypsin digestion procedure with two accelerated digestion protocols based on shorter reaction times and microwave-assisted digestion for the preparation of membrane-enriched protein fractions of the human pathogenic bacterium Staphylococcus aureus. Produced peptides were analyzed by Shotgun IPG-IEF, a methodology relying on separation of peptides by IPG-IEF before the conventional LC-MS/MS steps of shotgun proteomics. Data obtained on two LC-MS/MS platforms showed that accelerated digestion protocols, especially the one relying on microwave irradiation, enhanced the cleavage specificity of trypsin and thus improved the digestion efficiency especially for hydrophobic and membrane proteins. The combination of high-throughput proteomics with accelerated and efficient sample preparation should enhance the practicability of proteomics by reducing the time from sample collection to obtaining the results.


Subject(s)
High-Throughput Screening Assays/methods , Proteome/chemistry , Proteomics/methods , Staphylococcus aureus/chemistry , Bacterial Proteins/chemistry , Hydrolysis , Microwaves , Trypsin/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...